CapitolRadar

PAYX

CapitolRadar tracks every publicly disclosed PAYX trade by US congress members and corporate insiders: 33 disclosed trades (12 buys, 21 sells) by 7 tracked traders, from 2022-01-21 to 2026-08-25. Updated daily from official filings.

Disclosed trades33
Tracked buyers7
Last disclosed trade2026-08-25
Price$111.63

Want a ping when Congress buys PAYX? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free

Paychex, Inc. (PAYX) — Industrials · Staffing & Employment Services, market cap about $39.4B.

Cluster watch: 4 distinct tracked traders disclosed buying PAYX in the last 45 days: Michael McCaul, BONADIO TOM (director), Price Kevin A (director), TUCCI JOSEPH M (director).

CapitolRadar analysis

33 tracked trades skew toward sales

33 trades in Paychex (PAYX) were tracked from January 21, 2022 through August 25, 2026: 12 buys and 21 sells by seven distinct traders. Sales therefore represented about 64% of the activity, versus roughly 36% for buys. The totals show a sale-heavy record across the full period, but seven traders remain a small sample and aggregate direction does not establish any shared view or motive.

The listed quarterly snapshots are also sparse. They show one trade in 2026 Q3, a sale; one trade in 2026 Q2, a buy; and two trades in 2026 Q1, split evenly between buys and sells. The record lists one buy in 2025 Q4, one buy among three trades in 2025 Q3, one buy among two trades in 2025 Q2, and one sale in 2025 Q1. The only listed 2024 quarter, Q2, contains two sales. With one to three trades in each cited quarter, quarter-to-quarter comparisons are based on very small counts.

9 of 12 buys came from Ro Khanna

Ro Khanna recorded nine buys, with the latest dated April 13, 2026. Marjorie Taylor Greene recorded two buys, most recently on November 12, 2025, while Michael McCaul recorded one buy dated March 4, 2026. Together, these named buyers account for all 12 tracked purchases; Khanna alone represents 75% of them. That concentration means the buy count largely reflects one trader rather than a broad pattern across the seven tracked traders.

6 overlapping holdings appear among the buyers

Two of the PAYX buyers also bought each of DHR, MA, BAX, INTU, TER and BSX. These overlaps identify repeated co-purchases only; they do not show timing, position size or rationale.

Congressional disclosures can be filed up to 45 days after a transaction, so this activity is not a real-time signal. No transaction amounts are provided in these facts; where disclosed amount ranges are converted into values, those figures are estimates rather than exact trade sizes.

Analysis written from the tracked record on 2026-09-11; it is refreshed whenever the underlying numbers change.

Activity by quarter

QuarterDisclosed tradesBuysSells
2026 Q3101
2026 Q2110
2026 Q1211
2025 Q4110
2025 Q3312
2025 Q2211
2025 Q1101
2024 Q2202

Who is buying PAYX?

TraderDisclosed buysLast buyGrade
Ro Khanna92026-04-13—
Marjorie Taylor Greene22025-11-12—
Michael McCaul12026-03-04—

Disclosed trades in PAYX

DateWhoTypeAmount30d vs SPY
2026-08-25April Delaneysell$100,001 - $250,000—
2026-04-13Ro Khannabuy$1,001 - $15,000—
2026-03-04Michael McCaulbuy$100,001 - $250,000—
2026-01-13Ro Khannasell$1,001 - $15,000—
2025-11-12Marjorie Taylor Greenebuy$15,001 - $50,000—
2025-09-29Ro Khannabuy$1,001 - $15,000—
2025-08-26Ro Khannasell$1,000 - $15,000—
2025-08-26Ro Khannasell$1,001 - $15,000—
2025-05-05Marjorie Taylor Greenebuy$1,001 - $15,000—
2025-04-09Josh Gottheimersell$1,001 - $15,000—
2025-02-21Josh Gottheimersell$1,001 - $15,000—
2024-06-21Josh Gottheimersell$1,001 - $15,000—
2024-05-03Tommy Tubervillesell$1,001 - $15,000—
2023-11-03Ro Khannasell$1,001 - $15,000—
2023-10-10Ro Khannasell$1,001 - $15,000—
2023-10-02Ro Khannabuy$1,001 - $15,000—
2023-08-03Ro Khannabuy$1,001 - $15,000—
2023-06-26Ro Khannasell$1,001 - $15,000—
2023-05-23Ro Khannabuy$1,001 - $15,000—
2023-03-24Ro Khannasell$1,001 - $15,000—

CapitolRadar signal history

NEW PICK 2026-09-21

Rep. Michael McCaul reportedly bought Paychex stock, but the panel passed because the trade lacks a verified primary disclosure, date, amount, and filing lag. That missing information makes the reported purchase and its performance hard to confirm, while McCaul also has no verified trading record on file. A primary congressional filing confirming the purchase details and showing a timely entry followed by clear outperformance versus SPY could have changed the verdict.

These buyers also bought

Other stocks the tracked buyers of PAYX disclosed buying in the last six months: P (2) · ACN (2) · AMZN (2) · MA (2) · ISRG (2) · INTU (2).

About Paychex, Inc.

Founded in 1971 and headquartered in Rochester, New York, Paychex, Inc. delivers comprehensive human capital management (HCM) solutions. The company primarily serves small to medium-sized enterprises (SMEs) across the United States, Europe, and India, addressing their needs in human resources, payroll administration, employee benefits, and insurance. Its diverse service portfolio includes: Payroll Management: Encompassing core payroll processing, payroll tax administration, employee payment facilitation, and ensuring compliance with regulations like new-hire reporting and garnishment processin…

Frequently asked questions

Which politicians bought PAYX most?

Ro Khanna leads with 9 disclosed buys, followed by Marjorie Taylor Greene.

How current is this page?

It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.

Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.

Join CapitolRadar free

CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.